{"id":"W2171964208","doi":"10.3111/13696998.2012.667028","title":"Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thomson Reuters (Canada)","funders":"","keywords":"Medicine; Etanercept; Adalimumab; Infliximab; Rheumatoid arthritis; Internal medicine; Tumor necrosis factor alpha; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001255922,0.00012339,0.0003915339,0.0002538568,0.00005663414,0.00005023769,0.0002133904,0.0001462217,0.0001434046],"category_scores_gemma":[0.0004508382,0.00008863707,0.0001623346,0.0001197531,0.00009061203,0.0004086874,0.00003162865,0.0006437255,0.00001033506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001438571,"about_ca_system_score_gemma":0.00011919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001122684,"about_ca_topic_score_gemma":0.0005457014,"domain_scores_codex":[0.9982023,0.0002253286,0.0007200369,0.0001026557,0.0004227596,0.0003269117],"domain_scores_gemma":[0.9991013,0.0002654181,0.000258531,0.0001158288,0.00004583465,0.0002130331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001937794,0.0002686459,0.8716848,0.00000589005,0.00003791343,0.00004722678,0.004324669,0.000003713495,0.000005044579,0.0000407943,0.0001108049,0.1232767],"study_design_scores_gemma":[0.006482623,0.0003148612,0.9894611,0.000378253,0.000001447466,0.00004273784,0.001555453,0.0001208904,0.00002550123,0.0001034968,0.001425131,0.00008854696],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960486,0.002207041,0.00001004032,0.0009502516,0.0003972752,0.0002891923,0.00001206452,0.000005599552,0.00007990324],"genre_scores_gemma":[0.9633316,0.03581036,0.00006160364,0.0005868452,0.0001560648,0.00001046654,0.00002830947,0.00001403796,7.561475e-7],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1231882,"threshold_uncertainty_score":0.3614515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0204339455573577,"score_gpt":0.2750843191235194,"score_spread":0.2546503735661617,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}